Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-NY105 PET Imaging in Cancer
NCT05691881Phase 1Unknown
- Sponsor
- Affiliated Hospital of Jiangnan University
- Start
- Sep 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 68Ga-NY105 in cancer, sponsored by Affiliated Hospital of Jiangnan University. Primary endpoint: Evaluation of tissue distribution of 68Ga-NY105 at 1 day. Status: unknown.
02
Drugs
68Ga-NY105
03
Conditions
cancer
Beyond the preview
Go deeper on NCT05691881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05691881.